Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

MiR-200c and HuR in ovarian cancer

  • Silvia Prislei1,
  • Enrica Martinelli1,
  • Marisa Mariani1, 2,
  • Giuseppina Raspaglio1,
  • Steven Sieber2,
  • Gabriella Ferrandina3,
  • Shohreh Shahabi2,
  • Giovanni Scambia1, 3 and
  • Cristiano Ferlini2, 3Email author
BMC Cancer201313:72

https://doi.org/10.1186/1471-2407-13-72

Received: 27 September 2012

Accepted: 30 January 2013

Published: 8 February 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Sep 2012 Submitted Original manuscript
22 Oct 2012 Reviewed Reviewer Report - Dawn Cochrane
25 Oct 2012 Reviewed Reviewer Report - Jennifer Richer
23 Jan 2013 Author responded Author comments - Cristiano Ferlini
Resubmission - Version 2
23 Jan 2013 Submitted Manuscript version 2
Publishing
30 Jan 2013 Editorially accepted
8 Feb 2013 Article published 10.1186/1471-2407-13-72

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Laboratory of Antineoplastic Pharmacology, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart
(2)
Reproductive Tumor Biology Research, Biomedical Laboratory, Department of Obstetrics and Gynecology, Danbury Hospital Research Institute
(3)
Department of Oncology, Jean Paul IInd Research Foundation

Advertisement